2020 Exhibitors Search
QURATIS Inc.
Booth no.
G23
Exhibit Item |
[KOREA LIFE SCIENCE WEEK] Bio·Medical·Pharma
|
---|---|
Country | Korea, South |
Tel (Rep.) | 02-866-0604 |
Website | http://www.quratis.com |
Company Introduction
QURATIS is developing a tuberculosis vaccine (QTP101) for adolescents and adults. It has secured a number of new technologies that are more advanced than existing technologies in cooperation with excellent domestic and foreign research institutes. It is developing a product portfolio including a platform technology and PNA-based new concept antibiotics for various diseases. In September 2020, the Osong Bio Plant was completed, and CDMO service is also in progress.
Promotional Video
Exhibit Item
Exhibit Description
QTP101 is TB vaccine for adolescents and adults.
QTP101 has four antigens (three for virulence and one latency) and a synthetic adjuvant(GLA-SE) to boost the immunity, which is our key competitive advantage.
QTP101 has four antigens (three for virulence and one latency) and a synthetic adjuvant(GLA-SE) to boost the immunity, which is our key competitive advantage.
Co-Exhibitor or
Partner’s Information
Company Name | Country | Website |
---|